James Smith

Business Development Associate

James is a DPhil (PhD) student working on predicting the regulatory approval of early stage medicines using machine learning, and on improving IP landscaping practices. He has experience working as a consultant on a range of early stage biotech and medtech asset-focussed projects. Prior to his DPhil, James was a research scholar at the Harvard Stem Cell Institute, and completed his undergraduate degree in Biological Sciences at Oxford.

Other team Members

Neil Burns

View profile

Dr Nicholas Ibery

View profile

Dr Marek Tyl

Executive Chairman & Founder

View profile

Stathis Eleftheriadis

President

View profile

Professor Mischa Dohler

View profile
We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.